BCL2 and cancer: In recent years, numerous studies have indicated that apoptosis and related proteins and factors, including the Bcl-2 superfamily, p53, and PI3K–Akt signaling, may be crucial therapeutic targets in the treatment of cancers and may also trigger multi-drug resistance of some cancers to chemotherapy [29, 30, 32].